Reviews

Screening cancer patients for distress: guidelines for routine implementation

Screening cancer patients for distress during routine care is beginning to receive the attention it deserves, although it has long been known that distress has a negative impact on patients’ mental and physical health and that it can be managed through early identification and intervention. The National Comprehensive Cancer Network and the Institute of Medicine have created screening guidelines and recommendations for integrating routine distress screening as a quality standard in cancer care. In this article, we discuss a brief history of these guidelines, their implementation and barriers to implementation, methods for effective rapid screening in busy clinics, and future directions for networking among clinics and the dissemination of information.



 

The psychological and social consequences of cancer treatment were largely neglected until the latter part of the 20th century, despite the awareness that cancer patients often struggled with anxiety, depression, and emotional upheaval so severe as to jeopardize adherence to treatment. These psychological and emotional states were attributed to patients’ subjective responses to their condition, which were deemed unmeasurable and therefore not easily assessed in routine cancer care. Nevertheless, a study in the early 1980s1 showed that if newly diagnosed patients were screened for distress, those identified as being distressed could be helped to cope better.

To improve the recognition and treatment of distress in cancer patients, the National Comprehensive Cancer Network (NCCN) created a panel of experts in 1997 to formulate clinical practice guidelines for distress management.2 The guidelines, which were based on the evidence and consensus of an expert panel, were the first in the United States designed for clinicians. The term “distress” was chosen because it suggests a normal response, which can vary from an expected level to a severe one (eg, anxiety, depression).3 The term also reduces the stigma attached to words such as “psychiatric.”

The NCCN Distress Management Guidelines, which are updated annually, recommend that each new patient be rapidly assessed for distress in the office or clinic waiting room using a brief screening tool.3,4 Based on the lessons learned from the success of pain management, the panel suggested using the Distress Thermometer (DT), a self-report measure with a 0–10 scale in which 0 indicates “no distress” and 10, “extreme distress.” Patients who score 4 or more are identified as having clinically significant distress, based on validity studies showing sensitivity and specificity.5 They are then asked to check off the domains they identify as causing the distress in a separate Problem List. Depending on the nature of the problem elicited by the nurse or oncologist, patients can be referred to a professional, such as a social worker, nurse, psychologist, chaplain, or psychiatrist.6,7 The screen should be repeated at points of transition during clinical treatment.7

* For a PDF of the full article, click in the link to the left of this introduction.

Recommended Reading

IOM Urges Affordable Essential Benefits Package
MDedge Hematology and Oncology
Clinical Innovation
MDedge Hematology and Oncology
California Teen Tanning Ban Signed Into Law
MDedge Hematology and Oncology
Petitions Pile Up for Supreme Court Review of ACA
MDedge Hematology and Oncology
World Cancer Market Expected to Top $76 Billion by 2015
MDedge Hematology and Oncology
Megace Lawsuit Claims Right to Talk to Off-Label Prescribers
MDedge Hematology and Oncology
Drug Shortages Increasingly Take Toll on Care
MDedge Hematology and Oncology
CMS Issues Final Rule on Accountable Care Organizations
MDedge Hematology and Oncology
ACO Details Are Out: The Policy & Practice Podcast
MDedge Hematology and Oncology
Executive Order Aims to Help Alleviate Drug Shortages
MDedge Hematology and Oncology